Abstract
Bone mineral content (BMC) was measured by photon absorptiometry in the non-dominant forearm of children with chronic renal failure followed for a total of 2472 months. From 48 children, 302 measurements were made, and changes which occurred in BMC over time were correlated with several factors. Patients were divided into those who had received glucocorticoids (group 1) and those who had not (group 2). Group 1 patients had a lower mean serum creatinine (Cr) (p<0.05), a lower growth velocity (p>0.02) and were more demineralized than group 2 patients. There was no correlation between BMC and height velocity or estimated creatinine clearance. BMC and height Z-score (SDS) were highly correlated. Over the period of study, group 1 patients remained shorter, had a lower height velocity, a lower BMC Z-score and a lower BMC for each serum creatinine level. Long-term therapeutic intervention with oral 1,25(OH)2D improved bone mineral status in three children in the nonsteroid group, but none of those in the steroid group. This study demonstrates that steroid administration is probably the most important factor causing bone demineralization, possibly even more important than renal failure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mazess RB, Cameron JR (1972) Growth of bone in school children: comparison of radiographic morphometry and photon absorptiometry. Growth 36: 77–92
Mazess RB, Cameron JR (1974) Bone mineral content in normal U.S. whites. In: Mazess RB (ed) International Conference on Bone Mineral Measurement. US Department of Health, Education and Welfare, pp 228–238
Landin L, Nilsson BOE (1981) Forearm bone mineral content in children normative data. Acta Paediatr Scand 70: 919–923
Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF, Breed AL (1983) Long-term influence of calcitriol (1,25(OH)2D) and supplemental phosphate in X-linked hypophosphatemic rickets. Pediatrics 71: 559–567
Rosenbloom AL, Lezotte DC, Weber FT, Gudat J, Heller DR, Weber ML, Klein S, Kennedy BB (1977) Diminution of bone mass in childhood diabetes. Diabetica 26: 1052–1055
Mischler EH, Chesney J, Chesney RW, Mazess RB (1979) Demineralization in cystic fibrosis. Am J Dis Child 133: 632–635
Shore RM, Chesney RW, Mazess RB, Rose PG, Bargmann GJ (1982) Skeletal demineralization in Turner's syndrome. Calcif Tissue Int 34: 519–522
Chesney RW, Shore RM (1982) The noninvasive determination of bone mineral content by photon absorptiometry. Am J Dis Child 136: 578–580
Barden HS, Mazess RB, Chesney RW, Rose P, Chun RM (1982) Bone status of children receiving anticonvulsant therapy. Metab Bone Dis Relat Res 4: 37–43
Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ (1980) Bone mineral status in growth hormone deficiency. J Pediatr 96: 393–396
Hanly JG, McKenna MJ, Quigley C, Freaney R, Muldowney FP, Fitzgerald MX (1985) Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. Q J Med 56: 377–385
DeLuca HF, Schnoes HK (1983) Vitamin D recent advances. Annu Rev Biochem 52: 411–439
Chesney RW, Mazess RB, Rose PG, Jax DK (1977) Bone mineral status measured by direct photon absorptiometry in childhood renal disease. Pediatrics 60: 864–872
Chesney RW, Mazess RB, DeLuca HF (1980) The long-term influence of calcitriol on growth patterns in childhood renal osteodystrophy. In: Symposium: a clinical review of calcitriol. Excerpta Medica, Amsterdam-Princeton, p 7
Chesney RW, Mazess RB, Rose PG, Jax DK (1978) Effect of prednisone on growth and bone mineral content in childhood glomerular disease. Am J Dis Child 132: 768–772
Chesney RW, Rose PG, Mazess RB (1984) Persistence of diminished bone mineral content following renal transplantation in childhood. Pediatrics 73: 459–466
Schwartz GJ, Haycock GB, Edelman CM Jr, et al. (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259–263
Barratt TM, Broyer M, Chantler C, Gilli G, Guest G, Marti-Henneberg C, Preece MA, Rigden SPA (1986) Assessment of growth. Am J Kidney Dis 6: 340–346
Chesney RW, Holliday MA (1986) Growth in children (with Renal Introduction and Purpose Statement): Third International Workshop on Chronic Renal Insufficiency in children. Am J Kidney Dis 7: 225
Alfrey AC (1983) Aluminum. Adv Clin Chem 23: 69–91
Andreoli S, Bergstein JM, Sherrard DJ (1984) Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med 310: 1079–1984
Sedman AB, Miller NL, Warady BA, et. al. (1984) Aluminum loading in children with chronic renal failure. Kidney Int 26: 201–204
Griswold WR, Reznik V, Mendoza SA, et al. (1983) Accumulation of aluminum hydroxide. Pediatrics 71: 56–58
Bettinelli A, Bianchi ML, Aimini E, Ortolani S, Soldati L, Edefonti A (1986) Effects of 1,25-dihydroxyvitamin-D3 treatment on mineral balance in children with end stage renal disease undergoing chronic hemofiltration. Pediatr Res 20: 5–8
Author information
Authors and Affiliations
Additional information
Supported in part by funds from NIH grants: AM 31682, 37223 and Research Career Development Award K04 AM00421, by grants from Hoffman LaRoche Inc., and from Miles Laboratories.
Rights and permissions
About this article
Cite this article
Chesney, R.W., Rose, P., Mazess, R.B. et al. Long term follow-up of bone mineral status in children with renal disease. Pediatr Nephrol 2, 22–26 (1988). https://doi.org/10.1007/BF00870374
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00870374